La Fundación Clínica Shaio es un hospital en la localidad de Suba al noroccidente de Bogotá. Inició labores el 12 de abril de 1957. Sus fundadores son Fernando Valencia Céspedes y Alberto Vejarano Laverde, con una donación del filántropo sirio Abood Shaio.

During the past decade, Fundacion Clinica Shaio conducted 10 clinical trials. In the 10-year time frame, 10 clinical trials started and 7 clinical trials were completed, i.e. on average, 70% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 2 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Fundacion Clinica Shaio" #1 sponsor was "Actelion" with 4 trials, followed by "Boehringer Ingelheim" with 2 trials sponsored, "Shire" with 2 trials sponsored, "Fundación Cardioinfantil Instituto de Cardiología" with 1 trials sponsored and "Fundación Clínica Shaio" with 1 trials sponsored. Other sponsors include 2 different institutions and companies that sponsored additional 12 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Fundacion Clinica Shaio" #1 collaborator was "Universidad Autónoma de Bucaramanga" with 1 trials as a collaborator and "Universidad El Bosque, Bogotá" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Fundacion Clinica Shaio" are "Atrial Fibrillation" (3 trials), "Pulmonary Arterial Hypertension" (3 trials), "Acute Respiratory Failure" (1 trials), "Anticoagulant Antagonist Toxicity" (1 trials) and "COVID-19" (1 trials). Many other conditions were trialed in "Fundacion Clinica Shaio" in a lesser frequency.

Most popular intervention types in "Fundacion Clinica Shaio" are "Drug" (11 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "Macitentan" (2 trials), "25 mg Ontamalimab" (1 trials), "75 mg Ontamalimab" (1 trials) and "Apixaban" (1 trials). Other intervention names were less common.

The vast majority of trials in "Fundacion Clinica Shaio" are 17 trials for "All" genders.

Currently, there are NaN active trials in "Fundacion Clinica Shaio". undefined are not yet recruiting, 3 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 11 completed trials in Fundacion Clinica Shaio, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Fundacion Clinica Shaio, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 8 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 2 trials that are defined as “Not Applicable".